Treatment patterns and outcomes of patients with TP53-mutated chronic lymphocytic leukemia

被引：0
|
作者：
Hwang, Steven
Wang, Yucai
Rabe, Kari
Williams-Watley, Marquise
Kenderian, Saad
Muchtar, Eli
Hampel, Paul
Kay, Neil
Koehler, Amber
Behnken, Amy
Leis, Jose
Braggio, Esteban
Shi, Min
Viswanatha, David
Van Dyke, Daniel
Slager, Susan
Parikh, Sameer
He, Rong
Ding, Wei
机构：
来源：
LEUKEMIA & LYMPHOMA | 2023年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1550290
引用
收藏
页码：S84 / S85
页数：2
相关论文
共 50 条
  • [21] Outcomes with lower intensity therapy in TP53-mutated AML.
    Kadia, Tapan M.
    Boddu, Prajwal C.
    Ravandi, Farhad
    Garcia-Manero, Guillermo
    Borthakur, Gautam
    Andreeff, Michael
    Jabbour, Elias
    Dinardo, Courtney Denton
    Konopleva, Marina
    Daver, Naval Guastad
    Takahashi, Koichi
    Patel, Keyur
    Kanagal-Shamanna, Rashmi
    Cortes, Jorge E.
    Kantarjian, Hagop M.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [22] Immunohistochemistry for p53 Might Lead to Prompter Treatment in TP53-Mutated Acute Myeloid Leukemia
    Boiocchi, Leonardo
    Crabbe, Andrew
    Brunner, Andrew
    Fathi, Amir T.
    Hasserjian, Robert
    Nardi, Valentina
    LABORATORY INVESTIGATION, 2019, 99
  • [23] Immunohistochemistry for p53 Might Lead to Prompter Treatment in TP53-Mutated Acute Myeloid Leukemia
    Boiocchi, Leonardo
    Crabbe, Andrew
    Brunner, Andrew
    Fathi, Amir T.
    Hasserjian, Robert
    Nardi, Valentina
    MODERN PATHOLOGY, 2019, 32
  • [24] Clinical Impact Of Small TP53 Mutated Subclones In Chronic Lymphocytic Leukemia
    Rossi, Davide
    Khiabanian, Hossein
    Ciardullo, Carmela
    Spina, Valeria
    Bruscaggin, Alessio
    Fama, Rosella
    Monti, Sara
    Rasi, Silvia
    Wang, Jiguang
    Gattei, Valter
    Guarini, Anna
    FoA, Robin
    Rabadan, Raul
    Gaidano, Gianluca
    BLOOD, 2013, 122 (21)
  • [25] Clinical impact of small TP53 mutated subclones in chronic lymphocytic leukemia
    Rossi, Davide
    Khiabanian, Hossein
    Spina, Valeria
    Ciardullo, Carmela
    Bruscaggin, Alessio
    Fama, Rosella
    Rasi, Silvia
    Monti, Sara
    Deambrogi, Clara
    De Paoli, Lorenzo
    Wang, Jiguang
    Gattei, Valter
    Guarini, Anna
    Foa, Robin
    Rabadan, Raul
    Gaidano, Gianluca
    BLOOD, 2014, 123 (14) : 2139 - 2147
  • [26] Decitabine in TP53-Mutated AML Reply
    Welch, John S.
    Petti, Allegra A.
    Ley, Timothy J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (08): : 797 - 798
  • [27] Treatment outcomes for newly diagnosed, untreated TP53-mutated acute myeloid leukemia: A systematic review and meta-analysis.
    Daver, Naval Guastad
    Iqbal, Shahed
    Renard, Camille
    Chan, Rebecca J.
    Hasegawa, Ken
    Hu, Hao
    Tse, Preston
    Yan, Jiajun
    Zoratti, Michael J.
    Xie, Feng
    Ramsingh, Giridharan
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E19020 - E19020
  • [28] Targeting TP53-Mutated Acute Myeloid Leukemia: Research and Clinical Developments
    Granowicz, Eric M.
    Jonas, Brian A.
    ONCOTARGETS AND THERAPY, 2022, 15 : 423 - 436
  • [29] Patterns of recurrence in surgically treated women for TP53-mutated endometrial carcinomas
    Pain, Flore-Anne
    Beinse, Guillaume
    Azais, Henri
    Auvray-Kuentz, Marie
    Garcin, Louis-Marie
    Delanoy, Nicolas
    Bentivegna, Enrica
    Benoit, Louise
    Nguyen-Xuan, Huyen-Thu
    Blons, Helene
    Fabiano, Emmanuelle
    Belda, Marie-Aude L. E. Frere
    Bats, Anne-Sophie
    Koual, Meriem
    EJSO, 2023, 49 (09):
  • [30] TP53-mutated acute myeloid leukemia and myelodysplastic syndrome: biology, treatment challenges, and upcoming approaches
    Pereira, Mariana Pinto
    Herrity, Elizabeth
    Kim, Dennis D. H.
    ANNALS OF HEMATOLOGY, 2024, 103 (04) : 1049 - 1067
12345